Glucose-dependent insulinotropic polypeptide-mediated up-regulation of β-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2

Molecular and Cellular Biology

Volumn 28, Issue 5, 2008, Pages 1644-1656

  Kim, Su Jin ^a   Nian, Cuilan ^a   Widenmaier, Scott ^a   McIntosh, Christopher H S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GASTRIC INHIBITORY POLYPEPTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INCRETIN; PROTEIN BCL 2; PROTEIN TORC2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BETA GALACTOSIDASE; CASPASE 3; LUCIFERASE; TORC2 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE DELETION; GENE EXPRESSION; MUTAGENESIS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; UPREGULATION; ANIMAL; CELL CLONE; CELL CULTURE; CELL NUCLEUS; CELL SURVIVAL; CULTURE MEDIUM; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PROMOTER REGION; REPORTER GENE; RNA INTERFERENCE; STATISTICS;

RATTUS;

ANIMALS; BETA-GALACTOSIDASE; CASPASE 3; CELL CULTURE TECHNIQUES; CELL NUCLEUS; CELL SURVIVAL; CELLS, CULTURED; CLONE CELLS; CULTURE MEDIA; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION; GENES, REPORTER; INSULIN-SECRETING CELLS; LUCIFERASES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RNA INTERFERENCE; STATISTICS AS TOPIC; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 40749157994     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00325-07     Document Type: Article

References (58)

1. Bonner-Weir, S. 2001. Beta-cell turnover: its assessment and implications. Diabetes 50(Suppl. 1):S20-S24.
2. Bonner-Weir, S., D. Deery, J. L. Leahy, and G. C. Weir. 1989. Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes 38:49-53.
3. Brelje, T. C., J. A. Parsons, and R. L. Sorenson. 1994. Regulation of islet beta-cell proliferation by prolactin in rat islets. Diabetes 43:263-273.
4. Buteau, J., W. El-Assaad, C. J. Rhodes, L. Rosenberg, E. Joly, and M. Prentki. 2004. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia 47:806-815.
5. Butler, A. E., J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler. 2003. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110.
6. Chalovich, E. M., J. H. Zhu, J. Caltagarone, R. Bowser, and C. T. Chu. 2006. Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells. J. Biol. Chem. 281:17870-17881.
7. Ciani, E., S. Guidi, G. Della Valle, G. Perini, R. Bartesaghi, and A. Contestabile. 2002. Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation. J. Biol. Chem. 277:49896-49902.
8. Cory, S., and J. M. Adams. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2:647-656.
9. Cory, S., D. C. Huang, and J. M. Adams. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590-8607.
10. Cousin, S. P., S. R. Hugl, M. G. Jr. Myers, M. F. White, A. Reifel-Miller, and C. J. Rhodes. 1999. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signaling. Biochem. J. 15:649-658.
11. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
12. Drucker, D. J. 2003. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol. Endocrinol. 17:161-171.
13. Ehses, J. A., S. L. Pelech, R. A. Pederson, and C. H. S. McIntosh. 2002. Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway. J. Biol. Chem. 277:37088-37097.
14. Ehses, J. A., V. R. Casilla, T. Doty, J. A. Pospisilik, K. D. Winter, H. U. Demuth, R. A. Pederson, and C. H. S. McIntosh. 2003. Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase. Endocrinology 144:4433-4445.
15. Farilla, L., A. Bulotta, B. Hirschberg, Calzi. Li, N. Khoury, H. Noushmehr, C. Bertolotto, U. Di Mario, D. M. Harlan, and R. Perfetti. 2003. Glucagonlike peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149-5158.
16. Farilla, L., H. Hui, C. Bertolotto, E. Kang, A. Bulotta, U. Di Mario, and R. Perfetti. 2002. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143:4397-4408.
17. Gault, V. A., F. P. O'Harte, and P. R. Flatt. 2003 Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential? Neuropeptides 37:253-263.
18. Gonzalez, G. A., and M. R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675-680.
19. Gonzalez-Robayna, I. J., T. N. Alliston, P. Buse, G. L. Firestone, and J. S. Richards. 1999. Functional and subcellular changes in the A-kinase-signaling pathway: relation to aromatase and Sgk expression during the transition of granulosa cells to luteal cells. Mol. Endocrinol. 13:1318-1337.
20. Heckman, C. A., J. W. Mehew, and L. M. Boxer. 2002. NF-κB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 21:3898-3908.
21. 2]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats. Diabetes 51:652-661.
22. 2]incretin analogs: comparison of dipeptidyl peptidase IV resistance and biological activities in vitro and in vivo. J. Biol. Chem. 279:3998-4006.
23. Hockenbery, D. M., M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer. 1991. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88:6961-6965.
24. Hugl, S. R., M. F. White, and C. J. Rhodes. 1998. Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J. Biol. Chem. 273:17771-17779.
25. Hui, H., A. Nourparvar, X. Zhao, and R. Perfetti. 2003. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 144:1444-1455.
26. Hurley, R. L., L. K. Barre, S. D. Wood, K. A. Anderson, B. E. Kemp, A. R. Means, and L. A. Witters. 2006. Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J. Biol. Chem. 281:36662-36672.
27. Iwahashi, H., T. Hanafusa, Y. Eguchi, H. Nakajima, J. Miyagawa, N. Itoh, K. Tomita, M. Namba, M. Kuwajima, T. Noguchi, Y. Tsujimoto, and Y. Matsuzawa. 1996. Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. Diabetologia 39:530-536.
28. Jambal, P., S. Masterson, A. Nesterova, R. Bouchard, B. Bergman, J. C. Hutton, L. M. Boxer, J. E. Reusch, and S. Pugazhenthi. 2003. Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells. J. Biol. Chem. 278:23055-23065.
29. Jang, J. H., and Y. J. Surh. 2003. Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function. Biochem. Pharmacol. 66:1371-1379.
30. Jhala, U. S., G. Canettieri, R. A. Screaton, R. N. Kulkarni, S. Krajewski, J. Reed, J. Walker, X. Lin, M. White, and M. Montminy. 2003. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev. 17:1575-1580.
31. Kahn, B. B., T. Alquier, D. Carling, and D. G. Hardie. 2005. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1:15-25.
32. Kaszubska, W., R. Hooft van Huijsduijnen, P. Ghersa, A. M. DeRaemy-Schenk, B. P. Chen, T. Hai, J. F. DeLamarter, and J. Whelan. 1993 Cyclic AMP-independent ATF family members interact with NF-κB and function in the activation of the E-selectin promoter in response to cytokines. Mol. Cell. Biol. 13:7180-7190.
33. Kim, S. J., K. Winter, C. Nian, M. Tsuneoka, Y. Koda, and C. H. S. McIntosh. 2005. GIP stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3-K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1 and downregulation of bax expression. J. Biol. Chem. 280:22297-22307.
34. Kim, W. H., J. W. Lee, Y. H. Suh, H. J. Lee, S. H. Lee, Y. K. Oh, B. Gao, and M. H. Jung. 2007. AICAR potentiates ROS production induced by chronic high glucose: roles of AMPK in pancreatic beta-cell apoptosis. Cell Signal. 19:791-805.
35. Koo, S. H., L. Flechner, L. Qi, X. Zhang, R. A. Screaton, S. Jeffries, S. Hedrick, W. Xu, F. Boussouar, P. Brindle, H. Takemori, and M. Montminy. 2005. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437:1109-1111.
36. Lizcano, J. M., O. Goransson, R. Toth, M. Deak, N. A. Morrice, J. Boudeau, S. A. Hawley, L. Udd, T. P. Makela, D. G. Hardie, and D. R. Alessi. 2004. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23:833-843.
37. Mandrup-Poulsen, T. 2001. Beta-cell apoptosis: stimuli and signaling. Diabetes 50(Suppl. 1):S58-S63.
38. Mauricio, D., and T. Mandrup-Poulsen. 1998. Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 47:1537-1543.
39. Mehrhof, F. B., F. U. Muller, M. W. Bergmann, P. Li, Y. Wang, W. Schmitz, R. Dietz, and R. von Harsdorf. 2001. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation 104:2088-2094.
40. 2+ signaling in apoptosis of pancreatic cells and the impairment of glucose-induced insulin secretion. Endocrinology 139:1429-1439.
41. Nielsen, J. H. 1985. Growth and function of the pancreatic beta cell in vitro: effects of glucose, hormones and serum factors on mouse, rat and human pancreatic islets in organ culture. Acta Endocrinol. Suppl. (Copenh). 266:1-39.
42. Paris, M., C. Bernard-Kargar, M. F. Berthault, L. Bouwens, and A. Ktorza. 2003. Specific and combined effects of insulin and glucose on functional pancreatic beta-cell mass in vivo in adult rats. Endocrinology 144:2717-2727.
43. Pederson, R. A. 1994. Gastric inhibitory peptide, p. 217-259. In J. Walsh and G. Dockray (ed.), Gut peptides: biochemistry and physiology. Raven, New York, NY.
44. Pugazhenthi, S., A. Nesterova, C. Sable, K. A. Heidenreich, L. M. Boxer, L. E. Heasley, and J. E. Reusch. 2000. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J. Biol. Chem. 275:10761-10766.
45. Pugazhenthi, S., T. Boras, D. O'Connor, M. K. Meintzer, K. A. Heidenreich, and J. E. Reusch. 1999. Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. Involvement of p38 mitogen-activated protein kinase-mediated pathway. J. Biol. Chem. 274:2829-2837.
46. Rabinovitch, A., W. Suarez-Pinzon, K. Strynadka, Q. Ju, D. Edelstein, M. Brownlee, G. S. Korbutt, and R. V. Rajotte. 1999. Transfection of human pancreatic islets with an anti-apoptotic gene (Bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48:1223-1229.
47. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
48. Screaton, R. A., M. D. Conkright, Y. Katoh, J. L. Best, G. Canettieri, S. Jeffries, E. Guzman, S. Niessen, J. R. Yates III, H. Takemori, M. Okamoto, and M. Montminy. 2004. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119:61-74.
49. Shimabukuro, M., M. Y. Wang, Y. T. Zhou, C. B. Newgard, and R. H. Unger. 1998. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc. Natl. Acad. Sci. USA 95:9558-9561.
50. Smith, F. E., K. M. Rosen, L. Villa-Komaroff, G. C. Weir, and S. Bonner-Weir. 1991. Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc. Natl. Acad. Sci. USA 88:6152-6156.
51. Trümper, A., K. Trümper, and D. Hörsch. 2002. Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in β(INS-1)-cells. J. Endocrinol. 174:233-246.
52. Trümper, A., K. Trümper, H. Trusheim, R. Arnold, B. Göke, and D. Hörsch. 2001. Glucose-dependent insulinotropic polypeptide is a growth factor for β(INS-1) cells by pleiotropic signaling. Mol. Endocrinol. 15:1559-1570.
53. Unger, R. H., and L. Orci. 2002. Lipoapoptosis: its mechanism and its diseases. Biochim. Biophys. Acta 1585:202-212.
54. Vander Heiden, M. G., and C. B. Thompson. 1999. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat. Cell Biol. 1:E209-E216.
55. Wang, Q., L. Li, E. Xu, V. Wong, C. Rhodes, and P. L. Brubaker. 2004. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia 47:478-487.
56. Wilson, B. E., E. Mochon, and L. M. Boxer. 1996. Induction of Bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell. Biol. 16:5546-5556.
57. Xiang, H., J. Wang, and L. M. Boxer. 2006. The role of the cAMP-response element in the Bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells. Mol. Cell. Biol. 26:8599-8606.
58. Xing, J., J. M. Kornhauser, Z. Xia, E. A. Thiele, and M. E. Greenberg. 1998. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol. Cell. Biol. 18:1946-1955.